Table 2.

Hemodynamic and echocardiographic assessment of systemic administration of fluorescein- CSTSMLKAC on heart function in rats after ischemia/reperfusion injury.

	PBS	Homing peptide	Scrambled peptide
Hemodynamic measurement
Heart rate [beats/min]	444.8±13.14	454.75±13.88	430.75±20.59
End-systolic volume [μl]	309±33.9	280.76±15.91	260.91±10.99
End-diastolic volume [μl]	406.1±42.53	393.56±25.62	362.72±14.82
End-systolic pressure [mmHg]	107.5±9.2	119±3.16	120.1±3.48
End-diastolic pressure [mmHg]	3.87±0.35	3.96±0.67	3.08±0.22
Stroke volume [μl]	97.15±14.58	112.82±13.61	101.81±13.74
Ejection fraction [%]	23.79±2.79	28.44±2.09	27.89±3.01
Cardiac output [μl/min]	42640±5533	51430±6708	44530±7633
Cardiac index [ml/min per 100 g]	20.38±2.71	19.87±2.54	20.96±4.48
Echocardiography
Anterior wall thickness [mm]	2.01±0.06	2.00±0.04	2.08±0.08
Posterior wall thickness [mm]	1.81±0.09	1.73±0.10	1.83±0.06
End-systolic dimension [mm]	3.24±0.20	2.49±0.51	2.93±0.18
End-diastolic dimension [mm]	5.36±0.10	5.33±0.36	5.16±0.23
% Fractional shortening	39.39±4.35	54.05±6.72	43.20±3.22
Left ventricle mass [g]	655±30.24	635±84.31	646±55.48
LVM/BW	3.13±0.10	2.41±0.23	2.94±0.32
Body weight [g]	209.3±7.36	260.25±13.14	224±22.01